Family, twin and adoption studies provide strong evidence that genetic factors play a major role in the etiology of schizophrenia. While evidence has begun to accumulate for replicated linkage for schizophrenia to several chromosomal regions, efforts to identify the location of susceptibility loci for schizophrenia have previously proven unsuccessful. This may in part be true because prior studies of linkage disequilibrium (LD) were small in size, utilized a case control vs. a family based method, were ethnically and clinically heterogeneous and were conducted in large out-bred populations where LD may exist over only very short genetic distances. One of the studies that has contributed to these advances is the Irish Study of High Density Schizophrenia Families (ISHDSF), the original phase of which ascertained and studied, in Ireland and Northern Ireland, 265 multiplex schizophrenia families containing 1,408 individuals with detailed clinical information and DNA. In this third and final submission of this competitive renewal, we seek support to critically extend the ISHDSF by collecting 500 proband-parent triads for family-based association studies. We will select triads with a positive family history of psychosis to reduce the rate of """"""""phenocopies"""""""", interview parents for their personal and family history of schizophrenia and schizophrenia spectrum illness so as to weight transmissions on the basis of the probability that they contain a susceptibility allele and sample all living and available relatives with schizophrenia or chronic schizoaffective disorder so as to weight, in those triad-families, those that are more likely to be segregating a susceptibility allele in a given chromosomal region. With support for the genotyping and statistical analysis of this new sample, we seek to address two critical questions: 1. Can we replicate, by means of linkage disequilibrium, previously obtained evidence for linkage in the 4 putative susceptibility regions found in the ISHDSF to date (6p24-22, 8p22-21, 5q21-31 and 10p15-p11) and new regions that may emerge as we complete our genome scan? 2. Can we, by applying dense marker maps to our triad sample, obtain fine localization of schizophrenia susceptibility loci in these and other potential candidate regions? High genetic and cultural homogeneity, large family size, low rates of drug abuse, high levels of linkage disequilibrium demonstrated over genetic distances of 0.5 to 1.0 centiMorgans and a cooperative, stable population make Ireland ideal for linkage disequilibrium studies of schizophrenia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH041953-09A2
Application #
2858667
Study Section
Genome Study Section (GNM)
Program Officer
Moldin, Steven Owen
Project Start
1986-12-01
Project End
2003-03-31
Budget Start
1999-06-01
Budget End
2000-03-31
Support Year
9
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Chen, Qiaolin; Sugar, Catherine A; Weiss, Robert E (2018) A Bayesian confirmatory factor model for multivariate observations in the form of two-way tables of data. Stat Med 37:1696-1710
Singh, Tarjinder; Walters, James T R; Johnstone, Mandy et al. (2017) The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet 49:1167-1173
Han, Jun; Walters, James T R; Kirov, George et al. (2016) Gender differences in CNV burden do not confound schizophrenia CNV associations. Sci Rep 6:25986
Green, E K; Rees, E; Walters, J T R et al. (2016) Copy number variation in bipolar disorder. Mol Psychiatry 21:89-93
Franke, Barbara; Stein, Jason L; Ripke, Stephan et al. (2016) Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci 19:420-431
Edwards, Alexis C; Bigdeli, Tim B; Docherty, Anna R et al. (2016) Meta-analysis of Positive and Negative Symptoms Reveals Schizophrenia Modifier Genes. Schizophr Bull 42:279-87
Docherty, Anna R; Bigdeli, T Bernard; Edwards, Alexis C et al. (2015) Genome-wide gene pathway analysis of psychotic illness symptom dimensions based on a new schizophrenia-specific model of the OPCRIT. Schizophr Res 164:181-6
Heron, Elizabeth A; Cormican, Paul; Donohoe, Gary et al. (2014) No evidence that runs of homozygosity are associated with schizophrenia in an Irish genome-wide association dataset. Schizophr Res 154:79-82
Rees, Elliott; Walters, James T R; Chambert, Kimberly D et al. (2014) CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1. Hum Mol Genet 23:1669-76
Morris, Derek W; Pearson, Richard D; Cormican, Paul et al. (2014) An inherited duplication at the gene p21 Protein-Activated Kinase 7 (PAK7) is a risk factor for psychosis. Hum Mol Genet 23:3316-26

Showing the most recent 10 out of 148 publications